| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/18/2007 | WO2007055698A1 Improved method for making amino acid clycosides and glycopeptides |
| 05/18/2007 | WO2007055599A1 Compositions of cis-9, trans-11 conjugated linoleic acid and vaccenic acid and uses thereof |
| 05/18/2007 | WO2007055598A1 Treatment of mitochondria-related diseases and improvement of age-related metabolic deficits |
| 05/18/2007 | WO2007055563A2 Pharmaceutical combinations comprising testosterone in the treatment of female sexual dysfunction |
| 05/18/2007 | WO2007055514A1 Quinazoline derivatives as a multiplex inhibitor and method for the preparation thereof |
| 05/18/2007 | WO2007055513A1 Quinazoline derivatives as a signal transduction inhibitor and method for the preparation thereof |
| 05/18/2007 | WO2007055418A1 Aza-substituted spiro derivative |
| 05/18/2007 | WO2007055388A2 Calcium receptor activator |
| 05/18/2007 | WO2007055378A1 Method for treatment or prevention of disease associated with functional disorder of regulatory t cell |
| 05/18/2007 | WO2007055374A1 Therapeutic agent for osteoporosis |
| 05/18/2007 | WO2007055327A1 Jelly composition |
| 05/18/2007 | WO2007055325A2 Preventive/remedy for arteriosclerotic disease and method of evaluating therapeutic procedure |
| 05/18/2007 | WO2007055312A1 Plastic container filled with aqueous solution containing pyrazolone compound |
| 05/18/2007 | WO2007055279A1 Iontophoresis preparation |
| 05/18/2007 | WO2007055224A1 Therapeutic agent for corneal disease |
| 05/18/2007 | WO2007055184A1 Therapeutic or prophylactic agent for functional bowel disorder |
| 05/18/2007 | WO2007055183A1 Benzene derivative or salt thereof |
| 05/18/2007 | WO2007055105A1 Novel anthocyanin compound and method for producing same |
| 05/18/2007 | WO2007055093A1 Tricyclic compound |
| 05/18/2007 | WO2007054975A1 Pharmaceutical compositions for the treatment of cardiovascular and other associated disorders |
| 05/18/2007 | WO2007054968A2 Novel pharmaceutical compositions of clopidogrel mesylate |
| 05/18/2007 | WO2007054954A1 A novel pyrrolo[2,1-c][1,4]benzodiazepine hybrid and a process for the preparation thereof |
| 05/18/2007 | WO2007054911A2 Compositions useful for recovering original trophism and pigmentation, and for stimulating growth of the integumentary apparatus, uses and products thereof . |
| 05/18/2007 | WO2007054904A2 Macrolides as anti-inflammatory agents |
| 05/18/2007 | WO2007054822A2 Use of at least one avermectin or milbemycin in the treatment of ophthalmic pathologies |
| 05/18/2007 | WO2007054789A1 Pharmaceutical combination comprising atorvastatin derivatives |
| 05/18/2007 | WO2007054778A1 Pyrazolo[4,3-d]pyrimidin-5-yl)derivative used as pde5 inhibitors |
| 05/18/2007 | WO2007054777A1 Depletion of isomer in cephalosporin antibiotic |
| 05/18/2007 | WO2007054770A2 Pyrazole derivatives and their medical use |
| 05/18/2007 | WO2007054750A2 Process for the preparation of olanzapine |
| 05/18/2007 | WO2007054748A1 Indole derivatives as antitumoural compounds |
| 05/18/2007 | WO2007054741A1 Tetracyclic indole derivatives as antiviral agents |
| 05/18/2007 | WO2007054739A1 Tetrahydroindole derivatives for treatment of alzheimer's disease |
| 05/18/2007 | WO2007054731A1 Antiproliferative combination comprising cyc-682 and a cytotoxic agent |
| 05/18/2007 | WO2007054727A1 Combination of roscovitine and a hdca inhibitor to treat prolifeative diseases |
| 05/18/2007 | WO2007054725A2 Combination of a cdk-inhibitor and a hdac-inhibitor |
| 05/18/2007 | WO2007054719A2 Histone deacetylase (hdac) inhibitors (pxdlol) for the treatment of cancer alone or in combination with chemotherapeutic agent |
| 05/18/2007 | WO2007054717A2 STAUROSPORINE DERIVATIVES FOR THE TREATMENT OF LEUKEMIA CHARACTERISED BY A SPTBNl -FLT3 MUTATION |
| 05/18/2007 | WO2007054693A1 Use of pyrroloquinoline compounds to kill clinically latent microorganisms |
| 05/18/2007 | WO2007054623A2 Mammalian hedgehog signaling inhiabitors |
| 05/18/2007 | WO2007054601A1 1,1-dioxo-1,2,6-thadiazine 2-substituted 5-carboxylate and 5-carboxamide derivatives with cannabinoid properties |
| 05/18/2007 | WO2007054599A1 Oral formulations comprising 3'-azidonucleosides |
| 05/18/2007 | WO2007054580A1 N-sulfamoyl-n’-benzopyranpiperidines as inhbitors of carbonic anhydrases |
| 05/18/2007 | WO2007054579A1 Staurosporine derivatives for use in alveolar rhabdomyosarcoma |
| 05/18/2007 | WO2007054577A1 Cyclopropyl-fused pyrrolidine derivatives as dipeptidyl peptidase iv inhibitors |
| 05/18/2007 | WO2007054573A2 Anti-proliferative combination therapy comprising a platinum-based chemotherapeutic agent and egfr inhibitors or pyrimidine analogues |
| 05/18/2007 | WO2007054566A2 Use of fenofibrate or a derivative thereof for preventing diabetic retinopathy |
| 05/18/2007 | WO2007054556A1 Novel pyridopyrazines and their use as modulators of kinases |
| 05/18/2007 | WO2007054551A1 Combination treatment of cancer comprising egfr/her2 inhibitors |
| 05/18/2007 | WO2007054550A1 Quinazoline derivatives for the treatment of cancer diseases |
| 05/18/2007 | WO2007054531A1 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 05/18/2007 | WO2007054514A2 Use of pde iii inhibitors or calcium sensitizers for the treatment of asymptomatic (occult) heart failure |
| 05/18/2007 | WO2007054508A1 Pyrrolopyridines as kinase inhibitors |
| 05/18/2007 | WO2007054498A1 Aerosolformulation for inhalation |
| 05/18/2007 | WO2007054480A1 2-(benzimidazol-1-yl)-acetamide biaryl derivatives and their use as inhibitors of the trpv1 receptor |
| 05/18/2007 | WO2007054476A1 Use of flibanserin for the treatment of pre-menopausal sexual desire disorders |
| 05/18/2007 | WO2007054474A1 2-(benzimidazol-1-yl)-n-(4-phenylthiazol-2-yl) acetamide derivatives useful in treatment of trpv1 related disorders |
| 05/18/2007 | WO2007054451A1 Use of combinations of nitric oxide-releasing aspirin and aspirin for the treatment of cardiovascular diseases |
| 05/18/2007 | WO2007054444A2 3-aryl-isoxazole-4-carbonyl-benzofuran derivatives |
| 05/18/2007 | WO2007054436A2 Thiazolo [4 , 5-c] pyridine derivatives as mglu5 receptor antagonists |
| 05/18/2007 | WO2007054378A1 Anti-misuse microparticulate oral pharmaceutical form |
| 05/18/2007 | WO2007054357A1 Thiazole analogues and uses thereof |
| 05/18/2007 | WO2007054348A1 Novel medicaments |
| 05/18/2007 | WO2007054309A2 Use of clodronic acid for the treatment of navicular syndrome |
| 05/18/2007 | WO2007054302A1 Diaryl ureas for treating diabetic neuropathy |
| 05/18/2007 | WO2007054296A1 Macrolones |
| 05/18/2007 | WO2007054295A1 New 4*-substituted erythromycin derivative |
| 05/18/2007 | WO2007054294A1 Pyrazolo-pyrimidine derivatives as anti-inflammatory agents |
| 05/18/2007 | WO2007054292A2 Azonafide derivatives, methods for their production and pharmaceutical compositions therefrom |
| 05/18/2007 | WO2007054258A1 Dosage form for hormonal contraception |
| 05/18/2007 | WO2007054257A2 Indene derivatives, their preparation and use as medicaments |
| 05/18/2007 | WO2007054216A1 Diaryl urea for treating pulmonary hypertension |
| 05/18/2007 | WO2007054215A1 Diaryl ureas for treating pulmonary hypertension |
| 05/18/2007 | WO2007054197A1 Food products, ingredients therefor and use of those food products and ingredients |
| 05/18/2007 | WO2007054139A2 Styrylsulfonamides, their manufacture and use as pharmaceutical agents |
| 05/18/2007 | WO2007054138A1 Substituted tetrahydroquinolines |
| 05/18/2007 | WO2007054128A1 Novel inhibitors of the lfa-1/icam-1 interaction, and uses thereof |
| 05/18/2007 | WO2007053982A1 Chinese pharmaceutical compositions for treating epidemic cerebrospinal meningitis and processes for preparation thereof |
| 05/18/2007 | WO2007053956A1 Cancer antigen mage-a9 and uses thereof |
| 05/18/2007 | WO2007053945A1 Oral anti-microbial composition comprising competence-stimulating peptide |
| 05/18/2007 | WO2007053943A1 The use of compositions comprising ketoacids and amino acids for increasing muscle mass and muscle performance |
| 05/18/2007 | WO2007053935A1 Pharmaceutical compositions comprising polymeric binders with non-hydrolysable covalent bonds and their use in treating celiac disease |
| 05/18/2007 | WO2007053912A1 Use of angeloyl-substituted ingenanes in combination with other agents to treat cancer |
| 05/18/2007 | WO2007053902A1 Method of treating parasites |
| 05/18/2007 | WO2007053865A1 Pharmaceutical use of a compound |
| 05/18/2007 | WO2007036715A3 Compounds which have activity at m1 receptor and their uses in medicine |
| 05/18/2007 | WO2007035941A3 Transdermal galantamine delivery system |
| 05/18/2007 | WO2007035841A9 Analogs of dehydrophenylahistins and their therapeutic use |
| 05/18/2007 | WO2007034282A3 Diaryl-imidazole compounds condensed with a heterocycle as c3a receptor antagonists |
| 05/18/2007 | WO2007034278A3 Fused imidazole derivatives as c3a receptor antagonists |
| 05/18/2007 | WO2007034012A3 Method of obtaining amorphous calcium atorvastatin |
| 05/18/2007 | WO2007033239A3 Nanoparticulate tadalafil formulations |
| 05/18/2007 | WO2007031853A3 Therapeutic combination of hamlet and a hdac inhibitor to treat cancer |
| 05/18/2007 | WO2007031845A3 Polymorphic forms of (s)-omeprazole magnesium salts and processes for their preparation |
| 05/18/2007 | WO2007031833A3 Novel series of imidazolyl substituted steroidal and indan-1-one derivatives |
| 05/18/2007 | WO2007031832A3 Use of bipyridine compound 'caerulomycin a' derivatives and analogs thereof as immunosuppressive agents |
| 05/18/2007 | WO2007030680A3 Triazole derivatives useful as axl inhibitors |
| 05/18/2007 | WO2007029086A3 Derivatives of 3-azabicyclo[3.1.0]hexane as dipeptidyl peptidase-iv inhibitors |
| 05/18/2007 | WO2007029036A3 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
| 05/18/2007 | WO2007029035A3 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |